Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Neurodegenerative Diseases Market to 2018

Neurodegenerative Diseases Market to 2018

Views: 5|Likes:
Published by Bradley Greene

Bharat Book Presents"Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff"
analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal
trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD).

Bharat Book Presents"Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff"
analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal
trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD).

More info:

Categories:Types, Business/Law
Published by: Bradley Greene on Mar 30, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PPT, PDF, TXT or read online from Scribd
See more
See less

01/07/2015

pdf

text

original

 
 Neurodegenerative DiseasesMarket to 2018
Bharat Book Bureau
 
Summary
“Neurodegenerative Diseases Market to 2018
- New product entries in
 both niche and broader Parkinson’s disease treatment will boost marketdespite patent cliff”. A highly dynamic market scenario is expected in
 Neurodegenerative diseases in the next few years, with a number of  patent expiries and anticipated new drug approvals. The market for 
Alzheimer’s disease has not seen any recent major breakthroughs, and is
expected to experience a decline due to the patent expiry of several major 
 products. The market for Parkinson’s disease, on the other hand, is
expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US, in spite of the fact that itwill soon hit its own patent cliff. Additionally, the overall aging of  populations the developed world is expected to increase the number of  patients suffering from these diseases due to their relatively high prevalence in the elderly.
 
 
Continue…
 
Scope
 
- The report analyzes treatment usage patterns, market characterization, pipeline
analysis, and key M&A and licensing deal trends in Alzheimer’s Disease (AD),Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) andHuntington’s Disease (HD).
 - The current therapeutic environment in the treatment of AD, PD, HD and ALSacross the top seven developed markets, including the US, Germany, France, theUK, Italy, Spain and Japan.- Market data on the geographical landscape and therapeutic landscape, includingmarket size, annual cost of therapy, treatment usage patterns such as disease population and prescription populations.

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->